Matthew L. Maciejewski

Matthew L. Maciejewski

Auto-generated profile, based on publicly available information

Matthew L. Maciejewski

Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham, Veterans Affairs Medical Center, Durham, NC

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
MMMatthew L. Maciejewski
Matthew L. Maciejewski
DADavid E. Arterburn
David E. Arterburn
LSLynn Van Scoyoc
Lynn Van Scoyoc
VSValerie A. Smith
Valerie A. Smith
WYWilliam S. Yancy
William S. Yancy
MOMaren K. Olsen
Maren K. Olsen
Obesity is a chronic disease, and prior research has clearly demonstrated that bariatric surgery is the most effective intervention for inducing weight loss among obese patients.1-4 Much of this evidence is based on relatively short 1- to 3-year follow-up from randomized clinical trials3 that suggest that bariatric procedures are superior to nonsurgical interventions, Roux-en-Y gastric bypass (RYGB) induces greater weight loss than sleeve gastrectomy (SG), and RYGB and SG are superior to adjustable gastric banding (AGB) for weight loss.3,5

6 January 2015 in JAMA
Verified
Journal Article
Open access
PDF file
DADavid E. Arterburn
David E. Arterburn
MOMaren K. Olsen
Maren K. Olsen
VSValerie A. Smith
Valerie A. Smith
ELEdward H. Livingston
Edward H. Livingston
LSLynn Van Scoyoc
Lynn Van Scoyoc
MMMatthew L. Maciejewski
Matthew L. Maciejewski
Bariatric surgery is associated with improved weight, obesity-related comorbidities, and quality of life among severely obese adults.1-5 No long-term randomized clinical trials have been completed, but there is accumulating observational evidence that bariatric surgery is associated with better long-term survival than usual care.6-8

2 April 2019 in JAMA
Verified
Journal Article
Open access
PDF file
ENEdward C. Norton
Edward C. Norton
BDBryan E. Dowd
Bryan E. Dowd
MMMatthew L. Maciejewski
Matthew L. Maciejewski
Marginal effects can be used to express how the predicted probability of a binary outcome changes with a change in a risk factor. For example, how does 1-year mortality risk change with a 1-year increase in age or for a patient with diabetes compared with a patient without diabetes? This approach can make the results more easily understood. Marginal effects often are reported with logistic regression analyses to communicate and quantify the incremental risk associated with each factor.1,2

7 June 2018 in Biostatistics & Epidemiology
Verified
Journal Article
Closed access
MMMatthew L. Maciejewski
Matthew L. Maciejewski
Quasi-experiments are similar to randomized controlled trials in many respects, but there are many challenges in designing and conducting a quasi-experiment when internal validity threats are introduced from the absence of randomization. This paper outlines design, measurement and statistical issues that must be considered prior to the conduct of a quasi-experimental evaluation. We discuss challenges for the internal validity of quasi-experimental designs, inclusion/exclusion criteria, treatment and comparator cohort definitions, and the five types of explanatory variables that one must classify prior to analysis. We discuss data collection and confidentiality, statistical power and conclude with analytic issues that one must consider.

1 December 2012 in Medical Care
Verified
Journal Article
Closed access
KMKarina Melendez
Karina Melendez
MMMatthew L. Maciejewski
Matthew L. Maciejewski
RHRick H. Hoyle
Rick H. Hoyle
BRBryce B Reeve
Bryce B Reeve
PGPatrick Gallagher
Patrick Gallagher
WYWilliam S. Jr Yancy
William S. Jr Yancy
Background Self-report measures of medication nonadherence confound the extent of and reasons for medication nonadherence. Each construct is assessed with a different type of psychometric model, which dictates how to establish reliability and validity. Objectives: To evaluate the psychometric properties of a self-report measure of medication nonadherence that assesses separately the extent of nonadherence and reasons for nonadherence. Research Design: Cross-sectional survey involving the new measure and comparison measures to establish convergent, discriminant, and predictive validity. The new measure was readministered 2–21 days later. Subjects: A total of 202 veterans with treated hypertension were recruited from the Durham Veterans Affairs Medical Center. Measures: A new self-report measure assessed the extent of nonadherence and reasons for nonadherence. Comparison measures included self-reported medication self-efficacy, beliefs about medications, impression management, conscientiousness, habit strength, and an existing nonadherence measure. Results: Three items assessing the extent of nonadherence produced reliable scores for this sample, α=0.84 (95% confidence interval, 0.80–0.87). Correlations with comparison measures provided evidence of convergent and discriminant validity. Correlations with systolic (r=0.27, P<0.0001) and diastolic (r=0.27, P<0.0001) blood pressure provided evidence of predictive validity. Reasons for nonadherence were assessed with 21 independent items. Intraclass correlations were 0.58 for the extent score and ranged from 0.07 to 0.64 for the reasons. Conclusions: The dual conceptualization of medication nonadherence allowed a stronger evaluation of the reliability and validity than was previously possible with measures that confounded these 2 constructs. Measurement of self-reported nonadherence consistent with psychometric principles will enable reliable, valid evaluation of interventions to reduce nonadherence.

15 June 2011 in JAMA
Verified
Journal Article
Closed access
PDF file
MMMatthew L. Maciejewski
Matthew L. Maciejewski
ELEdward H. Livingston
Edward H. Livingston
VSValerie A. Smith
Valerie A. Smith
AKAndrew L. Kavee
Andrew L. Kavee
LKLeila C. Kahwati
Leila C. Kahwati
DADavid E. Arterburn
David E. Arterburn
Research from JAMA — Survival Among High-Risk Patients After Bariatric Surgery